Point72 (DIFC)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,653
Closed -$1.97M 1563
2025
Q2
$2.07M Buy
+2,653
New +$2.06M 0.08% 279
2025
Q1
Sell
-5,436
Closed -$4.52M 1895
2024
Q4
$4.2M Buy
+5,436
New +$4.5M 0.15% 189

Other funds holding LLY

Point72 (DIFC)'s LLY Position: Q3 2025 in Review

Point72 (DIFC) sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 2,653 shares — an estimated $1.97M sold.

Point72 (DIFC) first reported a position in LLY in Q4 2024 and held it in 2 quarters. The position peaked at $4.2M in Q4 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Point72 (DIFC) reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 2,653 Eli Lilly shares in Q3 2025, an estimated $1.97M.
  • Point72 (DIFC) first reported a position in Eli Lilly in Q4 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s Eli Lilly position peaked at $4.2M in Q4 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.